Immunovant holds annual stockholder meeting with 96% shares represented
IMVT•Annual stockholder meeting results
- Immunovant held its annual shareholder meeting on Sept. 2, 2026.
- Shareholders backed the selection of Ernst & Young as independent registered public accounting firm for fiscal 2027.
- Three directors were chosen to serve on the board through the 2027 annual meeting.
